Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

For patients with early-stage triple-negative breast cancer (TNBC), finishing chemotherapy and surgery should feel like the end of the hardest chapter. But for many, it marks the beginning of a ...

Social determinants of health and timely chemotherapy initiation. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component.

A real-world study of triple-negative breast cancer patients with brain metastases: A multicenter retrospective analysis. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This ...

Pottstown, Pennsylvania — Illeana Casiano-Vazquez and her husband Sam cherish every minute together. Six years ago, she was diagnosed with triple-negative breast cancer, an aggressive form of the ...

Please provide your email address to receive an email when new articles are posted on . Preoperative breast MRI provides no benefit in stage I or II hormone receptor-negative breast cancer. Five-year ...

Ten years after tailored radiotherapy (RT) for breast cancer, fewer than 3% of patients had locoregional recurrences (LRR), most during the first 5 years, a Dutch registry study showed. The overall ...

The risk of isolated locoregional recurrence after initial treatment was 5.6% among young women diagnosed with breast cancer. This was lower than a previously reported 10-year rate of 8% among all ...

ctDNA monitoring in esophageal and gastroesophageal cancers may detect recurrence earlier than traditional methods, offering a minimally invasive and sensitive approach. The Signatera assay showed ...